Data / Form D filings / LeanBio Therapeutics, Inc.
LeanBio Therapeutics, Inc.: Form D filing
LeanBio Therapeutics, Inc., a biotechnology company in Brookline, MA, filed a Form D with the SEC in 2026. The latest, on October 22, 2026, reports an offering of no set size with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 80 PARK STREET APT PH, Brookline, MA, 02446
- Phone
- (716) 655-7788
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 2160802
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michal Preminger | Executive Officer, Director | |
| William Hait | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Quiver Holdings Inc. $3 million · Oct 21
- Axelyf, Inc. $2.6 million · Oct 13
- BIOVENTRIX, INC. $1.2 million · Oct 8
- Opus KSD, Inc. $680,801 · Oct 1
Every Form D from the week of Oct 19 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LeanBio Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.